PharmSource Coverage of AACR 2017 Yields Valuable BD Info

by

You might have noticed it was a busy week on the PharmSource Lead Sheet. The beginning of April found myself and fellow Research Analyst, Mahdia Hashimy, covering the 2017 American Association for Cancer Research (AACR) conference in Washington DC. Here we gathered all the latest news and early research data in the oncology field from researchers from around the world. There was so much to report that 55% of our pipeline leads for the Lead Sheet Drug Edition for the Week of April 6th were in the oncology field, with 70% of these in Preclinical or Phase I.

The PharmSource research team actually covers a number of professional medical research conferences so we can provide information to our clients on the latest clinical product updates. The leads we gather from conferences are further researched and verified, including categorizing them so they can be identified by development phase, therapeutic area, API, dosage form, geographic territory, etc. We even show you molecular formulas, when available. And we verify contacts at each company we report on each week. Everything gets QC’ed by our editorial and technical quality control teams, then delivered directly to you in the PharmSource Lead Sheet. We really do the work for you!

Related posts:
Time to Hit the Road!
Using the PharmSource Lead Sheet Icons to Identify Early Opportunities
CRISPR: Gene Therapy 2.0

Brooke is a Senior Research Analyst at PharmSource, and heads the PharmSource Lead Sheet research team. Prior to joining the company in 2005, Brooke was a Scientific Research Assistant for a biotechnology company in Sydney, Australia. Brooke has a BS degree in Biotechnology with Honours from the University of Newcastle, Australia.

More posts by Brooke Wilson